Cargando…
Fuzapladib reduces postsurgical inflammation in the intestinal muscularis externa
Postoperative ileus (POI) is a surgical complication that induces emesis and anorexia. Fuzapladib (FUZ), an inhibitor of leukocyte-function-associated antigen type 1 (LFA-1) activation, a leukocyte adhesion molecule, exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflamm...
Autores principales: | KAJI, Noriyuki, IWAOKA, Kosuzu, NAKAMURA, Shinichiro, TSUKAMOTO, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686772/ https://www.ncbi.nlm.nih.gov/pubmed/37730381 http://dx.doi.org/10.1292/jvms.23-0257 |
Ejemplares similares
-
Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in
postoperative ileus
por: KIMURA, Hitomi, et al.
Publicado: (2022) -
Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis
por: Steiner, Joerg M., et al.
Publicado: (2023) -
Transcriptome profiling reveals significant changes in the gastric muscularis externa with obesity that partially overlap those that occur with idiopathic gastroparesis
por: Herring, B. Paul, et al.
Publicado: (2019) -
Molecular proinflammatory mechanism in the intestinal muscularis following intestinal manipulation
por: Kalff, JC, et al.
Publicado: (2001) -
Muscularis macrophages: Key players in intestinal homeostasis and disease
por: De Schepper, Sebastiaan, et al.
Publicado: (2018)